Bill > HR1627

This bill, known as the Telehealth Response for E-prescribing Addiction Therapy Services Act (TREATS Act), amends the Controlled Substances Act to expand telehealth options for substance use disorder treatment. Specifically, the bill modifies existing regulations to allow healthcare practitioners to prescribe certain controlled substances (specifically those in schedule III, IV, or V that are FDA-approved for substance use disorder treatment) after either a traditional in-person medical evaluation or a telehealth evaluation. The bill defines a "telehealth evaluation" as a medical consultation conducted remotely using telecommunications systems that enable two-way, real-time interactive communication, which can include audio-only or audio and video equipment. This change aims to increase access to addiction treatment by providing more flexible options for medical practitioners to assess and treat patients, particularly in situations where in-person visits might be challenging. The bill maintains existing requirements for practitioner qualifications and adherence to federal and state laws while creating a new pathway for remote medical evaluations in substance use disorder treatment.

Business and Industry

https://www.congress.gov/bill/119th-congress/house-bill/1627/all-info